b Tested in sodium chloride 0.9%.
c Tested in both dextrose 5% and sodium chloride 0.9%.
d Tested in bacteriostatic sodium chloride 0.9% preserved with benzyl alcohol 0.9%.
e Tested in dextrose 5% in Ringer’s injection, dextrose 5% in Ringer’s injection, lactated, dextrose 5%, Ringer’s injection, lactated, and sodium chloride 0.9%.
f Tested in dextrose 5% with sodium bicarbonate 0.05 mEq/mL.
g Lyophilized formulation tested.
h Refer to Appendix for the composition of parenteral nutrition solutions. TNA indicates a 3-in-1 admixture, and TPN indicates a 2-in-1 admixture.
i Injected via Y-site into an administration set running azithromycin.
j Test performed using the formulation WITHOUT edetate disodium.
k Tested in Ringer’s injection, lactated.
l Piperacillin component. Piperacillin in an 8:1 fixed-ratio concentration with tazobactam.
m Ceftolozane component. Ceftolozane in a 2:1 fixed-ratio concentration with tazobactam.
n Meropenem component. Meropenem in a 1:1 fixed-ratio concentration with vaborbactam.
o Test performed using the formulation WITH edetate disodium.
p Imipenem component. Imipenem in a 2:2:1 fixed-ratio concentration with relebactam.
r Sulbactam component. Sulbactam in a 1:1 fixed-ratio concentration with durlobactam.